Works by Michot, Jean-Marie

Results: 54
    1

    Age Does not Affect the Efficacy of Antibody Drug Conjugates, But is Associated with High-Grade Adverse Events in Patients with Cancer Enrolled in Early Phase Clinical Trials.

    Published in:
    Drugs & Aging, 2025, v. 42, n. 6, p. 583, doi. 10.1007/s40266-025-01212-6
    By:
    • Vaz Ferreira, Ana;
    • Delaye, Matthieu;
    • Pages, Arnaud;
    • Hollebecque, Antoine;
    • Gazzah, Anas;
    • Bahleda, Rastio;
    • Michot, Jean-Marie;
    • Danlos, Francois-Xavier;
    • Seknazi, Lauren;
    • Goldschmidt, Vincent;
    • Hénon, Clémence;
    • Sakkal, Madonna;
    • Smolenschi, Cristina;
    • Champiat, Stéphane;
    • Marabelle, Aurelien;
    • Loriot, Yohann;
    • Nagera Lazarovici, Céline;
    • Ap-Thomas, Zoé;
    • Beraud Chaullet, Geoffroy;
    • Ponce Aix, Santiago
    Publication type:
    Article
    2

    Immune checkpoint inhibitors-associated vasculitis: a heterogeneous condition with possible severe disease course.

    Published in:
    Rheumatology, 2025, v. 64, n. 6, p. 3685, doi. 10.1093/rheumatology/keae711
    By:
    • Chanson, Noemie;
    • Galvagni, Alexandre;
    • Ramos-Casals, Manuel;
    • Ruiz, Juan Ignacio;
    • Suijkerbuijk, Karijn P M;
    • Gente, Karolina;
    • Kerschen, Philippe;
    • Karam, Jean Denis;
    • Belkhir, Rakiba;
    • Outh, Rodereau;
    • Closs-Prophette, Fabienne;
    • Morillo, Jose Salvador Garcia;
    • Robles-Marhuenda, Ángel;
    • Michot, Jean-Marie;
    • Voisin, Anne Laure;
    • Messayke, Sabine;
    • Laparra, Arianne;
    • Robert, Caroline;
    • Suarez-Almazor, Maria;
    • Mariette, Xavier
    Publication type:
    Article
    3

    Renal toxicities associated with pembrolizumab.

    Published in:
    Clinical Kidney Journal, 2019, v. 12, n. 1, p. 81, doi. 10.1093/ckj/sfy100
    By:
    • Izzedine, Hassan;
    • Mathian, Alexis;
    • Champiat, Stephane;
    • Picard, Cécile;
    • Mateus, Christine;
    • Routier, Emilie;
    • Varga, Andrea;
    • Malka, David;
    • Leary, Alexandra;
    • Michels, Judith;
    • Michot, Jean-Marie;
    • Marabelle, Aurélien;
    • Lambotte, Olivier;
    • Amoura, Zahir;
    • Soria, Jean-Charles;
    • Kaaki, Sihem;
    • Quellard, Nathalie;
    • Goujon, Jean-Michel;
    • Brocheriou, Isabelle
    Publication type:
    Article
    4

    Patterns of progression in patients treated for immuno-oncology antibodies combination.

    Published in:
    Cancer Immunology, Immunotherapy, 2021, v. 70, n. 1, p. 221, doi. 10.1007/s00262-020-02647-z
    By:
    • Bernard-Tessier, Alice;
    • Baldini, Capucine;
    • Castanon, Eduardo;
    • Martin, Patricia;
    • Champiat, Stéphane;
    • Hollebecque, Antoine;
    • Postel-Vinay, Sophie;
    • Varga, Andreea;
    • Bahleda, Rastilav;
    • Gazzah, Anas;
    • Michot, Jean-Marie;
    • Ribrag, Vincent;
    • Armand, Jean-Pierre;
    • Marabelle, Aurélien;
    • Soria, Jean-Charles;
    • Massard, Christophe;
    • Ammari, Samy
    Publication type:
    Article
    5
    6

    When monoclonal gammopathy‐associated chronic neutrophilic leukemia is a reactive process distinct from a clonal myeloproliferative neoplasm: Lessons from mistakes.

    Published in:
    EJHaem, 2023, v. 4, n. 3, p. 823, doi. 10.1002/jha2.713
    By:
    • Willekens, Christophe;
    • Chahine, Claude;
    • Dragani, Matteo;
    • Khalife‐Hachem, Sabine;
    • Bigenwald, Camille;
    • Rossignol, Julien;
    • Castilla‐Llorente, Cristina;
    • Danu, Alina;
    • Michot, Jean‐Marie;
    • Saada, Veronique;
    • Cotteret, Sophie;
    • Marzac, Christophe;
    • Renneville, Aline;
    • Plo, Isabelle;
    • Broutin, Sophie;
    • Bosselut, Nelly;
    • Cassinat, Bruno;
    • Lazarovici, Julien;
    • Droin, Nathalie;
    • De Botton, Stephane
    Publication type:
    Article
    7

    Neurological complications induced by immune checkpoint inhibitors: a comprehensive descriptive case-series unravelling high risk of long-term sequelae.

    Published in:
    Brain Communications, 2021, v. 3, n. 4, p. 1, doi. 10.1093/braincomms/fcab220
    By:
    • Plaçais, Léo;
    • Michot, Jean-Marie;
    • Champiat, Stéphane;
    • Romano-Martin, Patricia;
    • Baldini, Capucine;
    • Joao, Maria Silva;
    • Marabelle, Aurélien;
    • Voisin, Anne-Laure;
    • Not, Adeline;
    • Labeyrie, Céline;
    • Beaudonnet, Guillemette;
    • Laparra, Ariane;
    • Maria, Alexandre T. J.;
    • Masseau, Agathe;
    • Dehette, Stéphanie;
    • Deleporte, Amélie;
    • Echaniz-Laguna, Andoni;
    • Denier, Christian;
    • Adams, David;
    • Lambotte, Olivier
    Publication type:
    Article
    8
    9
    10
    11
    12
    13

    Safety, recommended dose, efficacy and immune correlates for nintedanib in combination with pembrolizumab in patients with advanced cancers.

    Published in:
    Journal of Experimental & Clinical Cancer Research (17569966), 2022, v. 41, n. 1, p. 1, doi. 10.1186/s13046-022-02423-0
    By:
    • Baldini, Capucine;
    • Danlos, Francois-Xavier;
    • Varga, Andreea;
    • Texier, Matthieu;
    • Halse, Heloise;
    • Mouraud, Severine;
    • Cassard, Lydie;
    • Champiat, Stéphane;
    • Signolle, Nicolas;
    • Vuagnat, Perrine;
    • Martin-Romano, Patricia;
    • Michot, Jean-Marie;
    • Bahleda, Rastislav;
    • Gazzah, Anas;
    • Boselli, Lisa;
    • Bredel, Delphine;
    • Grivel, Jonathan;
    • Mohamed-Djalim, Chifaou;
    • Escriou, Guillaume;
    • Grynszpan, Laetitia
    Publication type:
    Article
    14
    15

    Immunosenescence, inflammaging, and cancer immunotherapy efficacy.

    Published in:
    2022
    By:
    • Rodriguez, Julieta E;
    • Naigeon, Marie;
    • Goldschmidt, Vincent;
    • Roulleaux Dugage, Matthieu;
    • Seknazi, Lauren;
    • Danlos, Francois X;
    • Champiat, Stephane;
    • Marabelle, Aurélien;
    • Michot, Jean-Marie;
    • Massard, Christophe;
    • Besse, Benjamin;
    • Ferrara, Roberto;
    • Chaput, Nathalie;
    • Baldini, Capucine
    Publication type:
    Literature Review
    16

    <sup>18</sup>F-FDG PET and CT Scans Detect New Imaging Patterns of Response and Progression in Patients with Hodgkin Lymphoma Treated by Anti-Programmed Death 1 Immune Checkpoint Inhibitor.

    Published in:
    Journal of Nuclear Medicine, 2018, v. 59, n. 1, p. 15, doi. 10.2967/jnumed.117.193011
    By:
    • Dercle, Laurent;
    • Seban, Romain-David;
    • Lazarovici, Julien;
    • Schwartz, Lawrence H.;
    • Houot, Roch;
    • Ammari, Samy;
    • Danu, Alina;
    • Edeline, Véronique;
    • Marabelle, Aurélien;
    • Ribrag, Vincent;
    • Michot, Jean-Marie
    Publication type:
    Article
    17
    18
    19

    Predicting Immunotherapy Outcomes in Older Patients with Solid Tumors Using the LIPI Score.

    Published in:
    Cancers, 2022, v. 14, n. 20, p. 5078, doi. 10.3390/cancers14205078
    By:
    • Pierro, Monica;
    • Baldini, Capucine;
    • Auclin, Edouard;
    • Vincent, Hélène;
    • Varga, Andreea;
    • Martin Romano, Patricia;
    • Vuagnat, Perrine;
    • Besse, Benjamin;
    • Planchard, David;
    • Hollebecque, Antoine;
    • Champiat, Stéphane;
    • Marabelle, Aurélien;
    • Michot, Jean-Marie;
    • Massard, Christophe;
    • Mezquita, Laura
    Publication type:
    Article
    20

    CD8+ T Lymphocytes Immune Depletion and LAG-3 Overexpression in Hodgkin Lymphoma Tumor Microenvironment Exposed to Anti-PD-1 Immunotherapy.

    Published in:
    Cancers, 2021, v. 13, n. 21, p. 5487, doi. 10.3390/cancers13215487
    By:
    • Michot, Jean-Marie;
    • Mouraud, Severine;
    • Adam, Julien;
    • Lazarovici, Julien;
    • Bigenwald, Camille;
    • Rigaud, Charlotte;
    • Tselikas, Lambros;
    • Dartigues, Peggy;
    • Danu, Alina;
    • Bigorgne, Amélie;
    • Minard, Veronique;
    • Ghez, David;
    • Marabelle, Aurélien;
    • Zitvogel, Laurence;
    • Ribrag, Vincent
    Publication type:
    Article
    21

    Cusatuzumab for treatment of CD70‐positive relapsed or refractory cutaneous T‐cell lymphoma.

    Published in:
    Cancer (0008543X), 2022, v. 128, n. 5, p. 1004, doi. 10.1002/cncr.34005
    By:
    • Leupin, Nicolas;
    • Zinzani, Pier Luigi;
    • Morschhauser, Franck;
    • Dalle, Stéphane;
    • Maerevoet, Marie;
    • Michot, Jean‐Marie;
    • Ribrag, Vincent;
    • Offner, Fritz;
    • Beylot‐Barry, Marie;
    • Moins‐Teisserenc, Hélène;
    • Zwaenepoel, Karen;
    • de Winne, Koen;
    • Battistella, Maxime;
    • Hultberg, Anna;
    • Gandini, Domenica;
    • Moshir, Mahan;
    • Jacobs, Julie;
    • Delahaye, Tim;
    • Khan, Aitzaz;
    • Zabrocki, Piotr
    Publication type:
    Article
    22
    23

    Phase I study of plitidepsin in combination with bortezomib and dexamethasone in patients with relapsed/refractory multiple myeloma.

    Published in:
    Cancer Medicine, 2023, v. 12, n. 4, p. 3999, doi. 10.1002/cam4.5250
    By:
    • Mateos, María Victoria;
    • Prosper, Felipe;
    • Martin Sánchez, Jesús;
    • Ocio, Enrique M.;
    • Oriol, Albert;
    • Motlló, Cristina;
    • Michot, Jean‐Marie;
    • Jarque, Isidro;
    • Iglesias, Rebeca;
    • Solé, María;
    • Martínez, Sara;
    • Kahatt, Carmen;
    • Fudio, Salvador;
    • Corral, Gema;
    • Zeaiter, Ali;
    • Montilla, Lola;
    • Ribrag, Vincent
    Publication type:
    Article
    24
    25
    26

    Kinetic Profiles and Management of Hepatitis B Virus Reactivation in Patients With Immune-Mediated Inflammatory Diseases.

    Published in:
    Arthritis Care & Research, 2013, v. 65, n. 9, p. 1504, doi. 10.1002/acr.21990
    By:
    • Droz, Nina;
    • Gilardin, Laurent;
    • Cacoub, Patrice;
    • Berenbaum, Francis;
    • Wendling, Daniel;
    • Godeau, Bertrand;
    • Piette, Anne-Marie;
    • Dernis, Emmanuelle;
    • Ebbo, Mikael;
    • Fautrel, Bruno;
    • Le Guenno, Guillaume;
    • Mekinian, Arsène;
    • Bernard-Chabert, Brigitte;
    • Costedoat-Chalumeau, Nathalie;
    • Descloux, Elodie;
    • Michot, Jean-Marie;
    • Radenne, Sylvie;
    • Rigolet, Aude;
    • Rivière, Sophie;
    • Yvin, Jean-Luc
    Publication type:
    Article
    27

    Exploring the Role of Target Expression in Treatment Efficacy of Antibody–Drug Conjugates (ADCs) in Solid Cancers: A Comprehensive Review.

    Published in:
    Current Oncology Reports, 2024, v. 26, n. 10, p. 1236, doi. 10.1007/s11912-024-01576-9
    By:
    • Mathiot, Laurent;
    • Baldini, Capucine;
    • Letissier, Octave;
    • Hollebecque, Antoine;
    • Bahleda, Rastislav;
    • Gazzah, Anas;
    • Smolenschi, Cristina;
    • Sakkal, Madona;
    • Danlos, François-Xavier;
    • Henon, Clémence;
    • Beshiri, Kristi;
    • Goldschmidt, Vincent;
    • Parisi, Claudia;
    • Patrikidou, Anna;
    • Michot, Jean-Marie;
    • Marabelle, Aurélien;
    • Postel-Vinay, Sophie;
    • Bernard-Tessier, Alice;
    • Loriot, Yohann;
    • Ponce, Santiago
    Publication type:
    Article
    28
    29

    Composite and sequential lymphoma between classical Hodgkin lymphoma and primary mediastinal lymphoma/diffuse large B‐cell lymphoma, a clinico‐pathological series of 25 cases.

    Published in:
    British Journal of Haematology, 2020, v. 189, n. 2, p. 244, doi. 10.1111/bjh.16331
    By:
    • Aussedat, Guillaume;
    • Traverse‐Glehen, Alexandra;
    • Stamatoullas, Aspasia;
    • Molina, Thierry;
    • Safar, Violaine;
    • Laurent, Camille;
    • Michot, Jean‐Marie;
    • Hirsch, Pierre;
    • Nicolas‐Virelizier, Emmanuelle;
    • Lamure, Sylvain;
    • Regny, Caroline;
    • Picquenot, Jean‐Michel;
    • Ledoux‐Pilon, Albane;
    • Tas, Patrick;
    • Chassagne‐Clément, Catherine;
    • Manson, Guillaume;
    • Lemal, Richard;
    • Fontaine, Juliette;
    • Le Cann, Marie;
    • Salles, Gilles
    Publication type:
    Article
    30

    Haemophagocytic histiocyte in a peripheral blood film.

    Published in:
    British Journal of Haematology, 2014, v. 165, n. 2, p. 163, doi. 10.1111/bjh.12697
    By:
    • Sloma, Ivan;
    • Vincent, Hélène;
    • Addebbous, Amal;
    • Rivoisy, Claire;
    • Turhan, Ali G.;
    • Michot, Jean‐Marie
    Publication type:
    Article
    31
    32
    33

    Relevance, Risks, and Benefits of Early‐Phases Clinical Trials Participations for Patients With Hematological Malignancies From 2008 to 2023.

    Published in:
    European Journal of Haematology, 2025, v. 114, n. 1, p. 89, doi. 10.1111/ejh.14307
    By:
    • Guerra, Matteo;
    • Alouani, Emily;
    • Hueso, Thomas;
    • Ouali, Kaissa;
    • Danu, Alina;
    • Hollebecque, Antoine;
    • Bahleda, Rastislav;
    • Willekens, Christophe;
    • Gazzah, Anas;
    • Baldini, Capucine;
    • Postel‐Vinay, Sophie;
    • Micol, Jean‐Baptiste;
    • Massard, Christophe;
    • De Botton, Stéphane;
    • Ribrag, Vincent;
    • Michot, Jean‐Marie
    Publication type:
    Article
    34

    High‐dose cyclophosphamide for hard‐to‐treat patients with relapsed or refractory B‐cell non‐Hodgkin's lymphoma, a phase II result.

    Published in:
    European Journal of Haematology, 2020, v. 104, n. 4, p. 281, doi. 10.1111/ejh.13369
    By:
    • Michot, Jean‐Marie;
    • Annereau, Maxime;
    • Danu, Alina;
    • Legoupil, Clémence;
    • Bertin, Louis;
    • Chahine, Claude;
    • Achab, Nadia;
    • Antosikova, Anna;
    • Cerutti, Ariane;
    • Rossignol, Julien;
    • Ghez, David;
    • Willekens, Christophe;
    • Dartigues, Peggy;
    • Lazarovici, Julien;
    • Lemare, Francois;
    • Ribrag, Vincent
    Publication type:
    Article
    35
    36

    In Situ Hepatitis C NS3 Protein Detection Is Associated with High Grade Features in Hepatitis C-Associated B-Cell Non-Hodgkin Lymphomas.

    Published in:
    PLoS ONE, 2016, v. 11, n. 6, p. 1, doi. 10.1371/journal.pone.0156384
    By:
    • Canioni, Danielle;
    • Michot, Jean-Marie;
    • Rabiega, Pascaline;
    • Molina, Thierry J.;
    • Charlotte, Frédéric;
    • Lazure, Thierry;
    • Davi, Frédéric;
    • Settegrana, Catherine;
    • Berger, Françoise;
    • Alric, Laurent;
    • Cacoub, Patrice;
    • Terrier, Benjamin;
    • Suarez, Felipe;
    • Sibon, David;
    • Dupuis, Jehan;
    • Feray, Cyrille;
    • Tilly, Hervé;
    • Pol, Stanislas;
    • Deau Fischer, Bénédicte;
    • Roulland, Sandrine
    Publication type:
    Article
    37
    38
    39
    40
    41
    42
    43

    Outcomes and prognostic factors for relapsed or refractory lymphoma patients in phase I clinical trials.

    Published in:
    Investigational New Drugs, 2018, v. 36, n. 1, p. 62, doi. 10.1007/s10637-017-0480-x
    By:
    • Michot, Jean-Marie;
    • Benajiba, Lina;
    • Faivre, Laura;
    • Baldini, Capucine;
    • Haddag, Lelia;
    • Bonnet, Clement;
    • Massard, Christophe;
    • Bigot, Frederic;
    • Bigenwald, Camille;
    • Verret, Benjamin;
    • Thomas, Zoé A. P.;
    • Varga, Andrea;
    • Gazzah, Anas;
    • Hollebecque, Antoine;
    • Ghez, David;
    • Lazarovici, Julien;
    • Balheda, Rastilav;
    • Jeanson, Aurore;
    • Postel-Vinay, Sophie;
    • Danu, Alina
    Publication type:
    Article
    44

    New insights on IgA vasculitis with underlying solid tumor: a nationwide French study of 30 patients.

    Published in:
    Clinical Rheumatology, 2021, v. 40, n. 5, p. 1933, doi. 10.1007/s10067-020-05455-z
    By:
    • Hankard, Antoine;
    • Michot, Jean-Marie;
    • Terrier, Benjamin;
    • Brihaye, Benoît;
    • Chanal, Johan;
    • Combe, Christian;
    • Karras, Alexandre;
    • Urbanski, Geoffrey;
    • Amoura, Zahir;
    • Darrigade, Anne-Sophie;
    • Deroux, Alban;
    • Guerville, Florent;
    • Burel, Le Sébastien;
    • Maigné, Gwénola;
    • Mekinian, Arsène;
    • Moulis, Guillaume;
    • Riviere, Etienne;
    • Vandamme-Giard, Carole;
    • Maillot, Francois;
    • De Boysson, Hubert
    Publication type:
    Article
    45

    Drug‐induced autoimmune hemolytic anemias related to immune checkpoint inhibitors, therapeutic management, and outcome.

    Published in:
    American Journal of Hematology, 2024, v. 99, n. 7, p. 1427, doi. 10.1002/ajh.27339
    By:
    • Plaçais, Marion;
    • Laparra, Ariane;
    • Maria, Alexandre Thibault Jacques;
    • Kramkimel, Nora;
    • Perret, Audrey;
    • Manson, Guillaume;
    • Comont, Thibault;
    • Coutte, Laetitia;
    • Nardin, Charlee;
    • Ouali, Kaissa;
    • Danlos, Francois‐Xavier;
    • Noël, Nicolas;
    • Messayke, Sabine;
    • Michel, Marc;
    • Lambotte, Olivier;
    • Michot, Jean‐Marie
    Publication type:
    Article
    46

    Sequence analyses of relapsed or refractory diffuse large B‐cell lymphomas unravel three genetic subgroups of patients and the GNA13 mutant as poor prognostic biomarker, results of LNH‐EP1 study.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 4, p. 645, doi. 10.1002/ajh.26835
    By:
    • Michot, Jean‐Marie;
    • Quivoron, Cyril;
    • Sarkozy, Clémentine;
    • Danu, Alina;
    • Lazarovici, Julien;
    • Saleh, Khalil;
    • El‐Dakdouki, Yolla;
    • Goldschmidt, Vincent;
    • Bigenwald, Camille;
    • Dragani, Matteo;
    • Bahleda, Rastislav;
    • Baldini, Capucine;
    • Arfi‐Rouche, Julia;
    • Martin‐Romano, Patricia;
    • Tselikas, Lambros;
    • Gazzah, Anas;
    • Hollebecque, Antoine;
    • Lacroix, Ludovic;
    • Ghez, David;
    • Vergé, Veronique
    Publication type:
    Article
    47
    48
    49

    Innovative therapies based on molecular orientation in patients with relapse and refractory diffuse large B‐cell lymphoma: Results of LNH‐EP1 study.

    Published in:
    American Journal of Hematology, 2021, v. 96, n. 10, p. E376, doi. 10.1002/ajh.26280
    By:
    • Sarkozy, Clémentine;
    • Michot, Jean‐Marie;
    • Quivoron, Cyril;
    • Camara‐Clayette, Valérie;
    • Danu, Alina;
    • Lazarovici, Julien;
    • El‐Dakdouki, Yolla;
    • Saleh, Khalil;
    • Ghez, David;
    • Rossignol, Julien;
    • Baldini, Capucine;
    • Arfi‐Rouche, Julia;
    • Romano‐Martin, Patricia;
    • Tselikas, Lambros;
    • Varga, Andrea;
    • Gazzah, Anas;
    • Hollebecque, Antoine;
    • Lacroix, Ludovic;
    • Bahleda, Rastislav;
    • Lecourt, Hélène
    Publication type:
    Article
    50